TACHIPIRINA*ORAL SUSP 120ML VAN/CAR

TACHIPIRINA 120 mg/5 ml oral suspension
Paracetamol

What it is and what it is used for
Tachipirina is an oral suspension containing the active ingredient paracetamol.
Paracetamol acts by reducing fever (antipyretic) and relieving pain (analgesic).
Tachipirina suspension is used in adults, adolescents and children weighing 7.2 kg (approximately 5-6 months) for:
- the symptomatic treatment of febrile conditions such as flu, eruptive diseases (infectious diseases typical of children and adolescents), acute respiratory tract diseases, etc.;
- pain of various origin and nature (headache, neuralgia, muscle pain and other moderate painful manifestations).

Consult your doctor if you/your child do not feel better or feel worse after 3 days of treatment.

What you need to know before taking the medicine
Do not use Tachipirina:
- if the person taking the medicine is allergic to paracetamol or any of the other ingredients of this medicine (listed in paragraph 6);
- if the person taking the medicine suffers from severe haemolytic anaemia (a disease due to the destruction of certain blood cells, red blood cells);
- if the person taking the medicine suffers from severe liver disease (severe hepatocellular insufficiency).

Warnings and precautions
Consult your doctor or pharmacist before using Tachipirina.
In the following cases, use Tachipirina with caution:
- if the person taking the medicine chronically or excessively consumes alcohol (3 or more alcoholic beverages per day);
- if the person taking the medicine suffers from anorexia (an eating disorder characterised by a lack or reduction of appetite);
- if the person taking the medicine suffers from bulimia (an eating disorder where a person ingests an excessive amount of food and then resorts to various methods to eliminate it);
- if the person taking the medicine suffers from cachexia (a state characterised by extreme thinness, reduction of muscle mass and thinning of the skin due to chronic diseases);
- if the person taking the medicine has been following an incorrect diet for a long time (chronic malnutrition);
- if the person taking the medicine suffers from dehydration (severe loss of water/fluids from the body);
- if the person taking the medicine suffers from hypovolemia (reduced blood volume in circulation);
- if the person taking the medicine has liver diseases that reduce its function (hepatic insufficiency, hepatitis, Gilbert's syndrome);
- if the person taking the medicine is undergoing concomitant treatment with drugs that alter liver function (see "Other medicines and Tachipirina");
- if the person taking the medicine suffers from glucose-6-phosphate dehydrogenase deficiency (a substance normally present in the human body, the deficiency of which can cause a blood disease);
- if the person taking the medicine suffers from haemolytic anaemia (a disease due to the destruction of certain blood cells, red blood cells).

Use of high doses and/or for prolonged periods
The use of high and/or prolonged doses of this medicine can cause even serious alterations to the kidney and blood. In these cases, the doctor will monitor liver and kidney function and blood composition over time through appropriate tests. Before taking this medicine, inform your doctor if the person taking the medicine suffers from kidney or liver disease.

Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you/your child experience the following side effects, STOP treatment with this medicine and contact your doctor immediately:
- allergic reactions with:
   - skin redness accompanied by itching (urticaria);
   - swelling of the throat (laryngeal oedema);
   - swelling of hands, feet, ankles, face, lips, tongue and/or throat (angioedema);
   - severe allergic reaction (anaphylactic shock).

In addition, the person taking the medicine may experience the following side effects, for which there are insufficient data to establish the frequency:
- reduction in the number of platelets in the blood (thrombocytopenia);
- reduction in the number of white blood cells in the blood (leukopenia/agranulocytosis);
- reduction of haemoglobin in the blood, a substance that carries oxygen in the blood (anaemia);
- dizziness;
- stomach and intestinal disorders;
- abnormal liver function;
- inflammation of the liver (hepatitis);
- red spots, blistering lesions with areas of skin detachment, blisters, skin rashes (erythema multiforme, Stevens Johnson syndrome, toxic epidermal necrolysis);
- reduction of kidney function (acute kidney failure);
- inflammation of the kidneys (interstitial nephritis);
- blood in the urine (haematuria);
- cessation or reduction of urine production (anuria).

Very rare cases of severe skin reactions have been reported.

Reporting of side effects
If you get any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects, you can help provide more information on the safety of this medicine.